Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 223,040Xls
2D Structure
Also known as: Reproxalap, Adx-102, 916056-79-6, Reproxalap [usan], Ns-2, Ald-102
Molecular Formula
C12H13ClN2O
Molecular Weight
236.70  g/mol
InChI Key
GUHFUVLKYSQIOQ-UHFFFAOYSA-N
FDA UNII
F0GIZ22IJH

Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjgren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(3-amino-6-chloroquinolin-2-yl)propan-2-ol
2.1.2 InChI
InChI=1S/C12H13ClN2O/c1-12(2,16)11-9(14)6-7-5-8(13)3-4-10(7)15-11/h3-6,16H,14H2,1-2H3
2.1.3 InChI Key
GUHFUVLKYSQIOQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)(C1=C(C=C2C=C(C=CC2=N1)Cl)N)O
2.2 Other Identifiers
2.2.1 UNII
F0GIZ22IJH
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Adx-102

2. Ald-102

3. Reproxalap

2.3.2 Depositor-Supplied Synonyms

1. Reproxalap

2. Adx-102

3. 916056-79-6

4. Reproxalap [usan]

5. Ns-2

6. Ald-102

7. F0giz22ijh

8. Reproxalap (usan)

9. Ns2

10. Reproxalap [inn]

11. Unii-f0giz22ijh

12. Adx102

13. Chembl4297210

14. Schembl12228833

15. Gtpl10613

16. Ex-a3715

17. Sb18931

18. Example 5 [wo2018039197a1]

19. Hy-107150

20. Cs-0027443

21. D11309

22. 2-(3-amino-6-chloroquinolin-2-yl)-propan-2-ol

23. 2-quinolinemethanol, 3-amino-6-chloro-alpha,alpha-dimethyl-

24. 2-quinolinemethanol, 3-amino-6-chloro-.alpha.,.alpha.-dimethyl-

2.4 Create Date
2007-06-18
3 Chemical and Physical Properties
Molecular Weight 236.70 g/mol
Molecular Formula C12H13ClN2O
XLogP32.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass236.0716407 g/mol
Monoisotopic Mass236.0716407 g/mol
Topological Polar Surface Area59.1 Ų
Heavy Atom Count16
Formal Charge0
Complexity259
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 Mechanism of Action

Reproxalap inhibits Reactive Aldehyde Species (RASP) and is being investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjgren-Larsson syndrome.